Monographie - Oxaliplatin

viimane versioon :
19/11/2024

Oxaliplatin

keemiline struktuur

Kaubanduslikud nimed erinevates maades

Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist

Axiplatin	Saksamaa
Bendaplatin	Saksamaa
Bioezulen	Brasiilia
Celdach	Maroko
Crisapla	Ecuador, Tšiili, Venetsueela
Crisatinox	Türgi
Dabenzol	Argentiina, Ecuador
Dacplat	Argentiina
Eloxarin	Ecuador
Eloxatin	Ameerika ühendriigid, Araabia Ühendemiraadid, Austria, Belgia, Brasiilia, Egiptus, Hispaania, Iraan, Itaalia, Kolumbia, Luksemburg, Malaisia, Maroko, Mehhiko, Norra, Portugal, Rootsi, Rumeenia, Suurbritannia, Sveits, Tai, Tšiili, Türgi, uus-Meremaa, Venetsueela
Eloxatine	Maroko, Prantsusmaa, Sveits
Entia	Kolumbia, Mehhiko
Euroxaliplatine	Saksamaa
Glenoxal	Maroko
Goxyral	Argentiina, Ecuador
Kebir	Argentiina, Maroko
Linoxa	Türgi
Lisix	Tšiili
Metaplatin	Argentiina
Oliptino	Argentiina
Onicol	Maroko, Tšiili
Oxalibbs	Brasiilia
Oxaliplan	Saksamaa
Riboxatin	Saksamaa

Viited : Oxaliplatin

	tüüp	avaldamine
1662	ajaleht	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1950	ajaleht	Trissel LA, Yanping Z. Physical and chemical stability of palonosetron HCl with cisplatin, carboplatin and oxaliplatin during simulated Y-site administration. J Oncol Pharm Practice 2004 ; 10: 191-195.
2207	ajaleht	André A, Cisternino S, Roy A.L, Chiadmi F, Schlatter J, Agranat P, Fain O, Fontan J.E. Stability of oxaliplatin in infusion bags containing 5% dextrose injection. Am J Health-Syst Pharm 2007 ; 64, 18: 1950-1954.
2239	ajaleht	Wang C, Zhang X, Liu HY. Determination of the stability of oxaliplatin for injection by dual wavelength spectrophotometry. Chinese J New Drugs 2005 ; 14, 2: 189-191.
2253	ajaleht	Curis E, Provost K, Bouvet D, Nicolis I, Crauste-manciet S, Brossard D, B?nazeth S. Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS. J Synchrotron Rad 2001 ; 8: 716-718.
2258	Labor	Stability of oxaliplatin "Ebewe" lyophilisate after reconstitution. Ebewe Pharma 2007
2259	Labor	Stability of oxaliplatin "Ebewe" lyophilisate infusion solutions. Ebewe Pharma 2007
2321	ajaleht	Junker A, Roy S, Desroches M.C, Moussay C, Berhoune M, Bellanger A, Fernandez C,Farinotti R. Stability of Oxaliplatin Solution. Ann Pharmacotherapy 2009 ; 43,2: 390-391.
2791	ajaleht	Mehta A.M,.Van den Hoven J.M, Rosing H,.Hillebrand M.J.X, Nuijen B,. Huitema A.D.R, Beijnen J.H,.Verwaal V.J. Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy. Int J Pharm 2015 ; 479 : 23-27.
2883	ajaleht	Eiden C, Philibert L, Bekhtari K, Poujol S, Malosse F, Fr?d?ric Pinguet F. Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags. Am J Health-Syst Pharm 2009 ; 66, 21: 1929-1933.
3369	Labor	Levofolinate de sodium Medac - Résumé des caractéristiques du produits MEDAC France 2011
3413	ajaleht	Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H. Oxaliplatin degradation in the presence of chloride: Identification and cytotoxicity of the monochloro monooxalato complex. Pharm Res 2004 ; 21, 5: 891-894.
3602	Labor	Mesna (Uromitexan®)- Summary of Product Characteristics Baxter SAS 2013
3634	Labor	Oxaliplatine (Oxaliplatine Accord®) - Résumé des caractéristiques du produit Accord Healthcare 2011
3670	ajaleht	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
3706	ajaleht	Escudero-Ortiz V, Duart-Duart M.J, P?rez-Ruixo C, P?rez-Ruixo J.J, Valenzuela B. Estudio de estabilidad de oxaliplatino y doxorrubicina para su administración intraperitoneal con hipertermia. Farm Hosp 2014 ;38, 3:154-161
4004	ajaleht	Krämer I, Sarakbi I, Thiesen J, Mainz. Physikalisch-chemische Stabilität von Oxaliplatin-beta-Infusionslösungskonzentrat und Infusionslösungen in 5 % Glucose in Polyolefin-Infusionsbeuteln. Krankenhauspharmazie 2017 ;38,7:334?340.

Mentions Légales